Exploratory study of urinary shedding products as a novel biomarker for early stage lung squamous cell carcinoma - A urinary biomarker for early stage lung squamous cell carcinoma

niversity of Miyazaki0 sites80 target enrollmentJanuary 18, 2018

Overview

No summary available.

Registry

who.int

Start Date

January 18, 2018

End Date

March 31, 2022

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

niversity of Miyazaki

•Patients with lung squamous cell carcinoma 1\.Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis. 2\.Patients who have renal dysfunction (Serum levels of creatinine \> 2\.0 mg/dl). 3\.Patients who do not undergo a curative surgery. 4\.Patients who have current malignant neoplasm other than lung squamous cell carcinoma, or past history of malignant neoplasm within 5 years. 5\.Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 6\.Patients who is pregnant or who is suspected to be pregnant. 7\.Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 8\.Patients who was not collected samples before curative surgery. 9\.Patients whose attending physicians consider to be inappropriate for this study. Healthy controls 1\.Those who have proteinuria, positive urine sugar or urine occult blood in urinalysis. 2\.Those who have past history of malignant neoplasm within 5 years. 3\.Those who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 4\.Those who are pregnant or who are suspected to be pregnant. 5\.Those who were enrolled another clinical trial and were prescribed a study drug within one month. 6\.Those who are current smokers or ex\-smokers. 7\.Those whose attending physicians consider to be inappropriate for this study.